Therapy News and Research

RSS

ACNAP-EuroHeartCare Congress 2022: Latest evidence on how to optimize cardiovascular care

Discover how patients with heart disease can live well, be healthy, and live longer at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).

6 May 2022

Antigen-presenting cancer-associated fibroblasts offer a new target to fight pancreatic cancer

Scar-like cells that make up a sizable portion of malignant pancreatic tumors and shield these cancers from immune attack are derived from mesothelial cells that line tissues and organs, a new study led by UT Southwestern researchers suggests.

6 May 2022

Applying a form of AI to sift through large amounts of biological data

Researchers at the University of Missouri are applying a form of artificial intelligence (AI) - previously used to analyze how National Basketball Association (NBA) players move their bodies - to now help scientists develop new drug therapies for medical treatments targeting cancers and other diseases.

6 May 2022

Stem cell therapy prevents type 1 diabetes induced by anti-cancer drugs

Immune checkpoint inhibitors are widely used to treat a variety of cancers; however, one serious side effect is the onset of type 1 diabetes.

6 May 2022

miRNAs associated with varying clinical presentations of SARS-CoV-2

A recent article published in the journal iSCIENCE demonstrated different micro ribonucleic acids (miRNAs) linked with various presentations of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

5 May 2022

Developing software solutions to monitor post-stroke rehabilitation and improve patient recovery

According to the study 'The impact of stroke in Europe', by King's College for the European Stroke Alliance, between 2015 and 2035 there will be a 34% increase in the number of cases in Europe (up to 819,771).

5 May 2022

Discovery provides critical clues to why many immunotherapies trigger dangerous side effects

It's not often that a failed clinical trial leads to a scientific breakthrough. When patients in the UK started showing adverse side effects during a cancer immunotherapy trial, researchers at La Jolla Institute for Immunology (LJI) Center for Cancer Immunotherapy and University of Liverpool went back through the data and worked with patient samples to see what went wrong.

5 May 2022

Fecal microbiota transplant can reverse hallmarks of aging in mice

In the search for eternal youth, poo transplants may seem like an unlikely way to reverse the aging process.

5 May 2022

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

...

From Dotmatics 5 May 2022

Blood vessels use endothelial communication system to control cardiovascular activity, study shows

An invisible lining of blood vessels uses a vast network of connections to control all cardiovascular functions and the risk of developing cardiovascular disease.

5 May 2022

Oral Nirmatrelvir's effects on long COVID symptoms

In a recent study posted to the Research Square* preprint server, researchers at the University of California, San Francisco, examined the cases of three individuals who received nirmatrelvir/ritonavir antiviral therapy at different stages following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

4 May 2022

Benefits of endurance exercise in primary mitochondrial disease depend on the underlying mutation

Mitochondria serve as the main source of energy production in our cells, and endurance exercise is generally known to improve the function of mitochondria.

4 May 2022

New insights into the cellular and molecular mechanisms of absence seizures

Bochum researchers have gained new insights into the cellular and molecular mechanisms of absence seizures and potential therapy options.

4 May 2022

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Weill Cornell Medicine researchers have identified a protein in Mycobacterium tuberculosis (Mtb) that contributes to drug tolerance, a phenomenon that allows bacteria to survive treatment with drugs that would normally kill them.

4 May 2022

Researchers overcome a major hurdle to reverse hearing loss due to aging

Hearing loss due to aging, noise and certain cancer therapy drugs and antibiotics has been irreversible because scientists have not been able to reprogram existing cells to develop into the outer and inner ear sensory cells -- essential for hearing – once they die.

4 May 2022

Therapy News and Research

ACNAP-EuroHeartCare Congress 2022: Latest evidence on how to optimize cardiovascular care

Antigen-presenting cancer-associated fibroblasts offer a new target to fight pancreatic cancer

Applying a form of AI to sift through large amounts of biological data

Stem cell therapy prevents type 1 diabetes induced by anti-cancer drugs

miRNAs associated with varying clinical presentations of SARS-CoV-2

Developing software solutions to monitor post-stroke rehabilitation and improve patient recovery

Discovery provides critical clues to why many immunotherapies trigger dangerous side effects

Fecal microbiota transplant can reverse hallmarks of aging in mice

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

Blood vessels use endothelial communication system to control cardiovascular activity, study shows

Oral Nirmatrelvir's effects on long COVID symptoms

Benefits of endurance exercise in primary mitochondrial disease depend on the underlying mutation

New insights into the cellular and molecular mechanisms of absence seizures

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Researchers overcome a major hurdle to reverse hearing loss due to aging

Evaluating a third SARS-CoV-2 mRNA vaccine in anti-CD20-treated patients

Phase 2 clinical trial of COVID-19 convalescent plasma with high antibody titers

How protection due to vaccination or previous SARS-CoV-2 infection varies for the population of the Czech Republic

New drug combinations for obesity and diabetes may show greater efficacy than single therapy

SARS-CoV-2 infection during pregnancy linked to adverse maternal outcomes and preterm birth

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News